MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts - PubMed (original) (raw)

Case Reports

MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts

A Chomyn et al. Proc Natl Acad Sci U S A. 1992.

Abstract

The pathogenetic mechanism of the mitochondrial tRNA(LeuUUR) gene mutation responsible for the MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes) syndrome was investigated in transformants obtained by transfer of mitochondria from three genetically unrelated MELAS patients into human mitochondrial DNA (mtDNA)-less (rho 0) cells. Marked defects in mitochondrial protein synthesis and respiratory activity were observed in transformants containing virtually pure mutant mtDNA, as compared to the parent of the rho 0 cells (the 143B cell line) or to transformants containing exclusively wild-type mtDNA, derived from one of the patients or a maternally related asymptomatic individual. A striking protective effect against the mutation was exerted in the transformants by levels of residual wild-type mtDNA above 6%. The MELAS mutation occurs within the mtDNA binding site for a protein factor (mTERF) that promotes termination of transcription at the 16S rRNA/tRNA(LeuUUR) gene boundary. A marked decrease in affinity of purified mTERF for the mutant target sequence was observed in in vitro assays. By contrast, RNA transfer hybridization experiments failed to show any significant change in the steady-state amounts of the two rRNA species, encoded upstream of the termination site, and of the mRNAs encoded downstream, in the transformants carrying the MELAS mutation.

PubMed Disclaimer

Cited by

Mitochondrial Transplantation for Ischemia Reperfusion Injury.
Doulamis IP, McCully JD. Doulamis IP, et al. Methods Mol Biol. 2021;2277:15-37. doi: 10.1007/978-1-0716-1270-5_2. Methods Mol Biol. 2021. PMID: 34080142
Linked oligodeoxynucleotides show binding cooperativity and can selectively impair replication of deleted mitochondrial DNA templates.
Taylor RW, Wardell TM, Connolly BA, Turnbull DM, Lightowlers RN. Taylor RW, et al. Nucleic Acids Res. 2001 Aug 15;29(16):3404-12. doi: 10.1093/nar/29.16.3404. Nucleic Acids Res. 2001. PMID: 11504878 Free PMC article.
Mitochondrial disease: mutations and mechanisms.
McKenzie M, Liolitsa D, Hanna MG. McKenzie M, et al. Neurochem Res. 2004 Mar;29(3):589-600. doi: 10.1023/b:nere.0000014829.42364.dd. Neurochem Res. 2004. PMID: 15038606 Review.
Mitochondrial DNA damage in non-melanoma skin cancer.
Durham SE, Krishnan KJ, Betts J, Birch-Machin MA. Durham SE, et al. Br J Cancer. 2003 Jan 13;88(1):90-5. doi: 10.1038/sj.bjc.6600773. Br J Cancer. 2003. PMID: 12556965 Free PMC article.
Metabolic remodelling associated with mtDNA: insights into the adaptive value of doubly uniparental inheritance of mitochondria.
Bettinazzi S, Rodríguez E, Milani L, Blier PU, Breton S. Bettinazzi S, et al. Proc Biol Sci. 2019 Feb 13;286(1896):20182708. doi: 10.1098/rspb.2018.2708. Proc Biol Sci. 2019. PMID: 30963924 Free PMC article.

References

1. Basic Appl Histochem. 1986;30(2):153-63 - PubMed
1. EMBO J. 1990 Oct;9(10):3405-11 - PubMed
1. Ann Neurol. 1986 Nov;20(5):573-82 - PubMed
1. Science. 1989 Oct 27;246(4929):500-3 - PubMed
1. Cell. 1989 Jul 28;58(2):391-7 - PubMed

MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts - PubMed (original) (raw)